Lucy Scientific Discovery Inc. (LSDI)
(Delayed Data from NSDQ)
$0.51 USD
-0.16 (-23.29%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $0.45 -0.06 (-12.43%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LSDI 0.51 -0.16(-23.29%)
Will LSDI be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for LSDI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LSDI
IPO Round Up of First Half of 2023
LSDI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for LSDI
Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Lucy Scientific Discovery receives Nasdaq notification of non-compliance
Lucy Scientific Discovery discloses Nasdaq non-compliance listing notice
12 Health Care Stocks Moving In Friday's After-Market Session
Tandem Diabetes Care, Guardion Health, GT Biopharma among healthcare movers